| Searching for the Optimal Treatment for Metallo-and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam. M Biagi, T Wu, M Lee, S Patel, D Butler, E Wenzler Antimicrobial agents and chemotherapy, AAC. 01426-19, 2019 | 89 | 2019 |
| Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat DA Butler, M Biagi, X Tan, S Qasmieh, ZP Bulman, E Wenzler Current infectious disease reports 21, 1-17, 2019 | 68 | 2019 |
| Pharmacokinetics, pharmacodynamics, and dose optimization of cefiderocol during continuous renal replacement therapy E Wenzler, D Butler, X Tan, T Katsube, T Wajima Clinical Pharmacokinetics, 1-14, 2022 | 22 | 2022 |
| A breath of fresh air in the fog of antimicrobial resistance: inhaled polymyxins for gram-negative pneumonia M Biagi, D Butler, X Tan, S Qasmieh, E Wenzler Antibiotics 8 (1), 27, 2019 | 21 | 2019 |
| Pharmacokinetics and Dialytic Clearance of Isavuconazole during In Vitro and In Vivo Continuous Renal Replacement Therapy M Biagi, D Butler, X Tan, S Qasmieh, K Tejani, S Patel, RM Rivosecchi, ... Antimicrobial Agents and Chemotherapy 63 (12), 10.1128/aac. 01085-19, 2019 | 16 | 2019 |
| Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib DA Butler, AP Rana, F Krapp, SR Patel, Y Huang, EA Ozer, AR Hauser, ... Journal of Antimicrobial Chemotherapy 76 (3), 671-679, 2021 | 13 | 2021 |
| AUC-based monitoring of vancomycin: closing the therapeutic window MJ Biagi, DA Butler, E Wenzler The Journal of Applied Laboratory Medicine 3 (4), 743-746, 2019 | 11 | 2019 |
| Exploring aztreonam in combination with ceftazidime-avibactam or meropenem-vaborbactam as potential treatments for metallo-and serine-β-lactamase-producing Enterobacteriaceae M Biagi, T Wu, M Lee, S Patel, D Butler, E Wenzler Antimicrobial Agents and Chemotherapy 63 (12), 10.1128/aac. 01426-19, 2019 | 10 | 2019 |
| Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data DA Butler, M Biagi, V Gupta, S Wieczorkiewicz, L Young, U Patel, ... Infection Control & Hospital Epidemiology 41 (12), 1409-1418, 2020 | 4 | 2020 |
| Reply to Baud and Houzé, “Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General … E Wenzler, M Biagi, X Tan, DA Butler Antimicrobial Agents and Chemotherapy 64 (6), 10.1128/aac. 00401-20, 2020 | 2 | 2020 |
| Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration DA Butler, K Moolick, D McCray, M Gifford Clinical Therapeutics 45 (11), 1137-1141, 2023 | | 2023 |
| Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy E Wenzler, D Butler, X Tan, T Katsube, T Wajima Clinical Pharmacokinetics 61 (7), 1069, 2022 | | 2022 |
| Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac (6')-Ib AP Rana, Y Huang, DA Butler, AR Hauser, F Krapp, EA Ozer, SR Patel, ... Oxford University Press, 2020 | | 2020 |
| 2269. Clinical Outcomes in Patients with Carbapenem-Non-Susceptible, β-Lactam-Susceptible Pseudomonas aeruginosa Infections. VM Gavaghan, M Lee, D Butler, M Biagi, M Santarossa, A Harrington, ... Open Forum Infectious Diseases 6, 2019 | | 2019 |
